Andere talen Sumitomo Pharma Co., Ltd.

Aandelen

4506

JP3495000006

Beurs gesloten - Japan Exchange Andere beurzen 08:00:00 07-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
341 ^JPY	+2,71%		+11,80%	-26,82%

14/05	Transcript : Sumitomo Pharma Co., Ltd., 2024 Earnings Call, May 14, 2024
14/05	Sumitomo Pharma Co. Geeft geconsolideerde winstverwachting voor het jaar eindigend op 31 maart 2024	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Sumitomo Pharma : Announces Organizational Realignment and Changes in the Positions Assumed by Executive Officer and Other Key Positions	03/06
Sumitomo Pharma : Posted Conference on FY2023 Financial Results	20/05
Poxel : un chiffre d'affaires trimestriel de 449000 euros	17/05
Sumitomo Chemical Co., Ltd. - Announcement of Finance Income, Restructuring Costs, and Extraordinary Loss in Non-consolidated Financial Statements	16/05
Sumitomo Pharma : May 14, 2024 Conference on FY2023 (April 1, 2023 to March 31, 2024) Financial Results	14/05
Sumitomo Pharma : Appoints Toru Kimura as President and CEO and Changes in Board of Directors Including Representative Directors, Executive Officer, and the Positions Assumed by Executive Officers	14/05
Sumitomo Pharma : Presentation Material (Conference on FY2023 Financial Results)	14/05
Sumitomo Pharma : Start of Phase 1 Clinical Study on Novel Universal Influenza Vaccine Candidate	14/05
Sumitomo Pharma Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2024	14/05
Sumitomo Pharma Co., Ltd. Announces No Dividend for the Year Ended March 31, 2024	14/05
Sumitomo Pharma : Notice of Company Split (Simplified Absorption-type Company Split) of the Frontier Business and Notice of Business Acquisition by a Wholly-Owned Subsidiary of the Company	09/05
Sumitomo Pharma : Notice of Company Split (Simplified Absorption type Company Split) of the Frontier Business and Notice of Business Acquisition by a Wholly Owned Subsidiary of the Company	09/05
Sumitomo Pharma Co., Ltd. agreed to acquire MELTz Business of MELTIN MMI Co., Ltd.	09/05
Profit-Taking, China Outlooks Churn Asian Stock Markets	07/05
Sumitomo Pharma : Posted Conference on Financial Forecasts Revision for FY2023 and Financial Forecasts for FY2024	07/05
Sumitomo Pharma : May 01, 2024 Conference on Financial Forecasts Revision for FY2023 and Financial Forecasts for FY2024 transcript	07/05
Fed Outlook, Earnings Season Roil Asian Stock Markets	02/05
Sumitomo Pharma Sees Impairment Losses and Restructuring Expenses in Fiscal 2024	02/05
Sumitomo Pharma Expects Substantial Valuation Loss on Subsidiary Shares; Assures No Impact on Consolidated Profit	02/05
Sumitomo Pharma : May 01, 2024 Conference on Financial Forecasts Revision for FY2023 and Financial Forecasts for FY2024	02/05

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Sumitomo Pharma Co., Ltd.

Aandelen

4506

JP3495000006

Andere talen

Filters